AVR anteris technologies global corp.

Ann: DurAVR First In Human Patient 6 Month Study Follow Up, page-8

  1. 303 Posts.
    lightbulb Created with Sketch. 113
    There was a study on Sapien 3 and Evolute R recovery rates.

    Increase from the baseline for the 6MWT was averaged at about 26-27%% for 30days and an extra 9% 30-60 days.

    We are significantly better than both valves. Especially considering %'s are exponential when quoting medical results.

    NFA DYOR
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$6.27
Change
0.360(6.09%)
Mkt cap ! $97.17M
Open High Low Value Volume
$5.93 $6.30 $5.91 $107.9K 17.39K

Buyers (Bids)

No. Vol. Price($)
1 3500 $6.12
 

Sellers (Offers)

Price($) Vol. No.
$6.27 200 1
View Market Depth
Last trade - 15.42pm 27/06/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.